About
Optain Health is a clinical AI company revolutionizing preventive healthcare through non-invasive retinal imaging. Their flagship Eyetelligence Assure solution pairs a portable automatic fundus camera with sophisticated AI algorithms to capture and analyze high-quality retinal images, identifying early signs of both eye diseases and systemic conditions such as cardiovascular disease risk—all in real time. The platform is designed as a ready-to-use, all-in-one turnkey solution that integrates seamlessly into any clinical environment, eliminating the need for extensive configuration, specialist training, or complex IT infrastructure. Clinicians simply capture a retinal photograph; Optain's AI immediately processes the image and generates a detailed risk assessment report supporting faster, more confident clinical decisions. Founded by world-leading experts in ophthalmology AI and backed by major health systems including Northwell Health, Optain serves a broad range of stakeholders: providers benefit from standardized, evidence-based screening guidance; patients receive comprehensive eye and whole-body health reports; and insurers can risk-stratify and monitor member populations at scale. Key advantages include non-invasive imaging, instant reporting, reduced risk of missed diagnoses, and democratized access to specialist-level screening. The platform is particularly valuable for high-pathology clinics, community health settings, and insurance wellness programs seeking affordable, scalable disease detection tools.
Key Features
- AI Retinal Image Analysis: Proprietary AI algorithms analyze full-color retinal images in real time to detect early signs of eye diseases and assess cardiovascular disease risk.
- Portable Automatic Fundus Camera: The Eyetelligence Assure camera is compact and easy to operate, capturing high-quality retinal images without requiring specialist ophthalmology training.
- Instant Risk Assessment Reports: Generates detailed, clinician-ready risk reports immediately after image capture, enabling faster decision-making and more confident patient consultations.
- Turnkey Clinic Integration: The all-in-one solution requires no complex setup, extensive configuration, or specialist IT support—ready to use out of the box in any clinical environment.
- Multi-Stakeholder Platform: Supports providers, patients, and insurers with tailored outputs including care recommendations, patient-facing health reports, and population-level risk stratification.
Use Cases
- Early detection of diabetic retinopathy, glaucoma, and macular degeneration in general practice or optometry clinics
- Cardiovascular disease risk screening integrated into routine eye examinations
- Population health risk stratification for health insurers and managed care organizations
- Supporting optometrists in borderline case assessment and reducing diagnostic uncertainty
- Expanding access to specialist-level disease screening in underserved or remote communities
Pros
- Non-Invasive and Fast: Retinal imaging is painless and non-invasive, with AI analysis delivering results instantly—improving clinical workflow without patient discomfort.
- No Specialist Training Required: The turnkey design eliminates the need for specialized ophthalmology expertise, making advanced disease screening accessible to general practice clinics.
- Founded by Leading Experts: Built by world-renowned ophthalmology AI researchers and backed by major health systems like Northwell Health, lending credibility and clinical rigor.
- Broad Disease Coverage: Screens for both ocular conditions and systemic diseases such as cardiovascular risk, delivering whole-body health insights from a single retinal scan.
Cons
- Hardware Dependency: Requires the proprietary Assure fundus camera, making it a capital investment that may be cost-prohibitive for smaller or resource-limited practices.
- Limited to Retinal-Based Screening: Disease detection is constrained to conditions that manifest detectable biomarkers in retinal images, which may not cover all health screening needs.
- Opaque Pricing: Pricing information is not publicly available, requiring direct engagement with the sales team, which can slow procurement decisions.
Frequently Asked Questions
What diseases can Optain Health detect?
Optain's AI analyzes retinal images to screen for referable eye diseases (such as diabetic retinopathy, glaucoma, and macular degeneration) and to evaluate cardiovascular disease risk, depending on the software option selected.
How does the AI retinal analysis work?
A clinician captures a full-color retinal photograph using the Eyetelligence Assure portable fundus camera. Optain's AI algorithms immediately process the image and generate a risk assessment report highlighting any signs of disease or elevated health risk.
Who is Optain designed for?
Optain serves healthcare providers (GPs, optometrists, clinics), insurers seeking population health risk stratification, and patients wanting comprehensive eye and systemic health insights.
Is the system difficult to integrate into an existing clinic?
No. The turnkey solution is designed for plug-and-play deployment with no complex IT setup, specialist configuration, or extensive staff training required.
Is Optain's software classified as a medical device?
Yes. Optain's software is a Software as a Medical Device (SaMD), developed to meet regulatory standards for clinical decision support in disease screening.
